Hidradenitis suppurativa: a systematic review and meta-analysis of therapeutic interventions

H Tchero, C Herlin, F Bekara, S Fluieraru… - Indian journal of …, 2019 - ijdvl.com
Hidradenitis suppurativa is a chronic inflammatory condition that affects skin regions bearing
apocrine glands. Although hidradenitis suppurativa is difficult to treat and cure, the currently …

Medical and surgical treatment of hidradenitis suppurativa: a review

N Scuderi, A Monfrecola, LA Dessy… - Skin Appendage …, 2017 - karger.com
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease presenting with painful
nodules, abscesses, sinus tracts, and scarring primarily affecting apocrine gland-rich …

Systematic review of immunomodulatory therapies for hidradenitis suppurativa

SYD Lim, HH Oon - Biologics: Targets and Therapy, 2019 - Taylor & Francis
Background: Greater understanding of the roles of tumor necrosis factor-α, IL-1β, IL-10, and
the IL-23/T-helper (Th) 17 and IL-12/Th1 pathways in immune dysregulation in …

Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process

JR Ingram, S Hadjieconomou… - British Journal of …, 2016 - academic.oup.com
The recent hidradenitis suppurativa (HS) Cochrane review identified outcome measure
heterogeneity as an important issue to address when designing future HS trials. Our …

The clinical significance of increased serum proinflammatory cytokines, C‐reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa

D Jiménez-Gallo… - Mediators of …, 2017 - Wiley Online Library
Objectives. To assess inflammatory serum markers including serum proinflammatory
cytokines, C‐reactive protein (CRP), and erythrocyte sedimentation rate (ESR) according to …

The psychosocial impact of hidradenitis suppurativa

M Gooderham, K Papp - Journal of the American Academy of Dermatology, 2015 - Elsevier
Increasingly, quality of life data are being captured along with other measures to evaluate
success in the treatment of numerous disease states. This is no less true in hidradenitis …

IL‐17A is a pertinent therapeutic target for moderate‐to‐severe hidradenitis suppurativa: Combined results from a pre‐clinical and phase II proof‐of‐concept study

AB Kimball, C Loesche, EP Prens… - Experimental …, 2022 - Wiley Online Library
Hidradenitis Suppurativa (HS) is a chronic, recurrent, inflammatory, follicular skin disease
whose pathology is complex and not fully understood. The objective of this study was to …

Efficacy and safety of biologics and small molecules for moderate-to-severe hidradenitis suppurativa: a systematic review and network meta-analysis

YC Tsai, CY Hung, TF Tsai - Pharmaceutics, 2023 - mdpi.com
Background: Treatment of hidradenitis suppurativa (HS) is difficult and current guidelines
are based mainly on expert opinion and non-randomized controlled trials. Recently, there …

Inter‐rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa

L Thorlacius, A Garg, PT Riis… - British Journal of …, 2019 - academic.oup.com
Background Monitoring disease activity over time is a prerequisite for clinical practice and
research. Valid and reliable outcome measurement instruments (OMIs) and staging systems …

A cross‐sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP)

E Delany, G Gormley, R Hughes… - Journal of the …, 2018 - Wiley Online Library
Background Hidradenitis suppurativa (HS), a chronic inflammatory disease that affects
apocrine gland–bearing skin, has a significant impact on patients' quality of life. Estimates of …